Annual Meeting

Must-See Sessions for Tuesday, May 11

ASGCT Staff - May 10, 2021

Here are some sessions not to miss on May 11, the first day of the 24th Annual Meeting.

Make sure you catch these sessions on the first day of #ASGCT21! Please note that all meeting sessions will be available on demand for registered attendees for 30 days following the conclusion of the meeting.

10-11:45 a.m. (ET)

COVID-19: Vaccines to the Rescue

This symposium will feature a roundtable discussion representing the viewpoints of a number of individuals involved in the creation and testing of mRNA and adenovirus vaccines for COVID-19.  Topics will include lessons learned through clinical validation of vaccines, adverse events, and real-world events as well as opinions on boosters, variants, and durability.  The session will also include discussion on experiences in developing vaccines in the context of a pandemic touching on media attention, Operation Warp Speed, and other unique facets of the rollout of the vaccines on a global scale.

Gene Therapy Development Challenges and Opportunities in Low- and Middle-Income Countries (Organized by the Global Outreach Committee)

This symposium will address access to gene therapy in low- to middle-income countries (LMICs), with a focus on the middle-income countries of Brazil, India, and South Africa, due to their infrastructural capacity to provide gene therapy combined with their proximity to low-income countries.

12-1 p.m. (ET)

Fireside Chat with Jennifer Doudna

Jennifer A. Doudna, Ph.D., the co-recipient of the 2020 Nobel Prize in Chemistry, will join us for a live fireside chat.

3:30-5:15 p.m. (ET)

Career Development Award Presentations

Learn about the research of 2019 Career Development Award winners Geoffrey Rogers, Ph.D., Kshitiz Singh, Ph.D., Christopher Nelson, Ph.D., Daniel Kiss, Ph.D., and Kalpana Parvathaneni, Ph.D.

ASGCT/ASTCT Joint Session: Next Generation CAR T Cell Therapies

During this joint session, speakers will discuss iNKT-CAR, engineering human pluripotent stem cells to produce NK cells with improved anti-tumor activity, CAR macrophage and myeloid cell advances, and CAR-T for T cell NHL.

Share This Page

Related Articles

Annual Meeting

Global Speakers Address Developing Gene Therapies in Low- and Middle-Income Countries

Martín Bonamino, Ph.D. - June 03, 2021
Annual Meeting

Q&A with Bruce Pyenson

Francesca Cook, MPH - June 03, 2021
Annual Meeting

COVID-19 Vaccines to the Rescue

Edith Pfister, Ph.D. - May 28, 2021
Annual Meeting

Gene Therapy Progress: Challenges and Opportunities

Emily Walsh Martin, Ph.D. - May 26, 2021